eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2016
vol. 67
 
Share:
Share:
abstract:
Review paper

Are mast cells important in diabetes?

Duraisamy Kempuraj
1
,
Alessandro Caraffa
2
,
Gianpaolo Ronconi
3
,
Gianfranco Lessiani
4
,
Pio Conti
5

  1. Department of Neurology, Carver College of Medicine, University of Iowa, Iowa, USA
  2. Department of Pharmacology, University of Perugia, Perugia, Italy
  3. Policlinico Gemelli, Rome, Italy
  4. Villa Serena Hospital, Città Sant’Angelo, Italy
  5. Postgraduate Medical School, Università G. d’Annunzio, Chieti, Italy
Pol J Pathol 2016; 67 (3): 199-206
Online publish date: 2016/11/25
View full text Get citation
 
PlumX metrics:
Diabetes is a metabolic disorder characterized by hyperglycemia and associated with microvascular and macrovascular syndromes mediated by mast cells. Mast cells are activated through cross-linking of their surface high affinity receptors for IgE (FcRI) or other antigens, leading to degranulation and release of stored inflammatory mediators, and cytokines/chemokines without degranulation. Mast cells are implicated in innate and acquired immunity, inflammation and metabolic disorders such as diabetes. Histamine and tryptase genes in mast cells are overexpressed in pancreatic tissue of type 2 diabetes mellitus (T2DM) patients. Histamine is a classic inflammatory mediator generated by activated receptors of mast cells from the histamine-forming enzyme histidine decarboxylase (HDC), which can be activated by two inflammatory chemokines, RANTES and MPC1, when injected intramuscularly or intradermally in mice. This activation is inhibited in genetically mast cell-deficient W/Wv mice, which show higher insulin sensitivity and glucose tolerance. This study contributes to understanding the mechanism by which mast cells profoundly affect diabetes, and their manipulation could represent a new therapeutic strategy. However, further studies are needed to clarify the role of mast cells in inflammation and metabolic disorders such as diabetes.
keywords:

type 1 diabetes, type 2 diabetes, mast cells, autoimmunity, immune modulation, peripheral vascular disease

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.